Clopidogrel and aspirin in patients with atrial fibrillation - ACTIVE A study (Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)

被引：1
|
作者：
Moser, M. [1 ]
Bode, C. [1 ]
Nitschmann, S.
机构：
[1] Univ Freiburg Klinikum, D-79106 Freiburg, Germany
来源：
INTERNIST | 2010年 / 51卷 / 01期
关键词：
D O I：
10.1007/s00108-009-2573-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：100 / 102
页数：3
相关论文
共 50 条
  • [1] Clopidogrel und ASS für Patienten mit VorhofflimmernACTIVE-A-Studie (Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)Clopidogrel and aspirin in patients with atrial fibrillationACTIVE A study (Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)
    M. Moser
    C. Bode
    S. Nitschmann
    Der Internist, 2010, 51 : 100 - 102
  • [2] Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])
    Perera, Kanjana S.
    Pearce, Lesly A.
    Sharma, Mukul
    Benavente, Oscar
    Connolly, Stuart J.
    Hart, Robert G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (05): : 584 - 589
  • [3] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
    Connolly, S.
    Pogue, J.
    Hart, R.
    Pfeffer, M.
    Hohnloser, S.
    Chrolavicius, S.
    Yusuf, S.
    LANCET, 2006, 367 (9526): : 1903 - 1912
  • [4] Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
    Connolly, S.
    Yusuf, S.
    Budaj, A.
    Camm, J.
    Chrolavicius, S.
    Commerford, P. J.
    Flather, M.
    Fox, K. A. A.
    Hart, R.
    Hohnloser, S.
    Joyner, C.
    Pfeffer, M.
    Anand, I.
    Arthur, H.
    Avezum, A.
    Bethala-Sithya, M.
    Blumenthal, M.
    Ceremuzynski, L.
    De Caterina, R.
    Diaz, R.
    Flaker, G.
    Frangin, G.
    Franzosi, M. -G.
    Gaudin, C.
    Golitsyn, S.
    Goldhaber, S.
    Granger, C.
    Halon, D.
    Hermosillo, A.
    Hunt, D.
    Jansky, P.
    Karatzas, N.
    Keltai, M.
    Lanas, F.
    Lau, C. P.
    Le Heuzey, J. -Y.
    Lewis, B. S.
    Morais, J.
    Morillo, C.
    Oto, A.
    Paolasso, E.
    Peters, R. J.
    Pfisterer, M.
    Piegas, L.
    Pipillis, T.
    Proste, C.
    Sitkei, E.
    Swedberg, K.
    Synhorst, D.
    Talajic, M.
    AMERICAN HEART JOURNAL, 2006, 151 (06) : 1187 - 1193
  • [5] Comparison of clopidogrel plus aspirin versus oral anticoagulation for prevention of vascular events in patients with atrial fibrillation: Results of atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W) randomized controlled trial
    Abramkin, D. V.
    KARDIOLOGIYA, 2006, 46 (08) : 52 - 53
  • [6] Anticoagulation in Atrial Fibrillation Active-Study (Aterial fibrillation Clopidogrel Trail with Irbesartan for prevention of Vascular Events)
    Meinertz, T.
    INTERNIST, 2007, 48 (08): : 874 - 875
  • [7] Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk - The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W)
    Healey, Jeff S.
    Hart, Robert G.
    Pogue, Janice
    Pfeffer, Marc A.
    Hohnloser, Stefan H.
    De Caterina, Raffaele
    Flaker, Greg
    Yusuf, Salim
    Connolly, Stuart J.
    STROKE, 2008, 39 (05) : 1482 - 1486
  • [8] Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
    Seet, Raymond Chee-Seong
    Chen, Christopher P. L.
    STROKE, 2009, 40 (12) : 3883 - 3885
  • [9] Clopidogrel plus aspirin in the prevention of thromboembolism in atrial fibrillation: Results of the clopidogrel aspirin atrial fibrillation (CLAAF)-pilot study
    Lorenzoni, R
    Cocci, F
    Lazzerini, G
    De Caterina, R
    CIRCULATION, 2002, 106 (19) : 181 - 181
  • [10] The safety of clopidogrel for the prevention thromboembolic events in patients with atrial fibrillation
    Yigit, Z
    Ökçün, B
    Küçükoglu, S
    Sansoy, V
    Güzelsoy, D
    EUROPEAN HEART JOURNAL, 2003, 24 : 168 - 168
12345